AbsEn.i
Analysis
2020
Racine
Analysis
2020
Exploration
Accueil
Racine
Racine

Serveur d'exploration Stress et Covid - Analysis (2020)

Index « AbsEn.i » - entrée « angiotensin »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
angiogenesis < angiotensin < angles  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 18.
Ident.Authors (with country if any)Title
000086 (2020) Paolo Verdecchia ; Claudio Cavallini ; Antonio Spanevello ; Fabio AngeliThe pivotal link between ACE2 deficiency and SARS-CoV-2 infection
000113 (2020) Peter P. Liu [Canada] ; Alice Blet [France] ; David Smyth [Canada] ; Hongliang Li [République populaire de Chine]The Science Underlying COVID-19: Implications for the Cardiovascular System.
000142 (2020) Rinkoo Dalan [Singapour] ; Stefan R. Bornstein [Singapour] ; Ali El-Armouche [Allemagne] ; Roman N. Rodionov [Allemagne] ; Alexander Markov [Russie] ; Ben Wielockx [Allemagne] ; Felix Beuschlein [Suisse] ; Bernhard O. Boehm [Singapour]The ACE-2 in COVID-19: Foe or Friend?
000181 (2020) Gianluca Trifir [Italie] ; Salvatore Crisafulli [Italie] ; Giuseppe And [Italie] ; Giorgio Racagni [Italie] ; Filippo Drago [Italie]Should Patients Receiving ACE Inhibitors or Angiotensin Receptor Blockers be Switched to Other Antihypertensive Drugs to Prevent or Improve Prognosis of Novel Coronavirus Disease 2019 (COVID-19)?
000185 (2020) Shu-Ren Li ; Zi-Jian Tang [République populaire de Chine] ; Zai-Han Li ; Xuan Liu [République populaire de Chine]Searching therapeutic strategy of new coronavirus pneumonia from angiotensin-converting enzyme 2: the target of COVID-19 and SARS-CoV
000192 (2020) Sonja Gro [Allemagne] ; Christopher Jahn [Allemagne] ; Sarah Cushman [Allemagne] ; Christian B R [Allemagne] ; Thomas Thum [Allemagne]SARS-CoV-2 receptor ACE2-dependent implications on the cardiovascular system: From basic science to clinical implications
000216 (2020) Muthiah Vaduganathan ; Orly Vardeny ; Thomas Michel ; John J. V. Mcmurray ; Marc A. Pfeffer ; Scott D. SolomonRenin–Angiotensin–Aldosterone System Inhibitors in Patients with Covid-19
000278 (2020) Zhong Sun ; Karuppiah Thilakavathy ; S. Suresh Kumar [Malaisie] ; Guozhong He [République populaire de Chine] ; Shi V. Liu [États-Unis]Potential Factors Influencing Repeated SARS Outbreaks in China
000442 (2020) Reinhold Kreutz [Allemagne] ; Engi Abd El-Hady Algharably [Allemagne] ; Michel Azizi [France] ; Piotr Dobrowolski [Pologne] ; Tomasz Guzik [Pologne] ; Andrzej Januszewicz [Pologne] ; Alexandre Persu [Belgique] ; Aleksander Prejbisz [Pologne] ; Thomas Günther Riemer [Allemagne] ; Ji-Guang Wang [République populaire de Chine] ; Michel Burnier [Suisse]Hypertension, the renin–angiotensin system, and the risk of lower respiratory tract infections and lung injury: implications for COVID-19
000462 (2020) Antoinette Maassenvandenbrink ; Tessa De Vries ; A. H. Jan DanserHeadache medication and the COVID-19 pandemic
000529 (2020) Kevin A. Bobeck ; Arthur W. Holtzclaw ; Tara E. Brown ; Paul A. ClarkEffective Use of Angiotensin II in Coronavirus Disease 19–Associated Mixed Shock State: A Case Report
000593 (2020) Andrew M. South [États-Unis] ; Laurie Tomlinson [Royaume-Uni] ; Daniel Edmonston [États-Unis] ; Swapnil Hiremath ; Matthew A. Sparks [États-Unis]Controversies of renin–angiotensin system inhibition during the COVID-19 pandemic
000640 (2020) Yu Kang [États-Unis] ; Tiffany Chen [États-Unis] ; David Mui [États-Unis] ; Victor Ferrari [États-Unis] ; Dinesh Jagasia [États-Unis] ; Marielle Scherrer-Crosbie [États-Unis] ; Yucheng Chen [République populaire de Chine] ; Yuchi Han [États-Unis]Cardiovascular manifestations and treatment considerations in covid-19.
000729 (2020) Eleanor Murray ; Maciej Tomaszewski [Royaume-Uni] ; Tomasz J. Guzik [Royaume-Uni]Binding of SARS-CoV-2 and angiotensin-converting enzyme 2: clinical implications
000760 (2020) Erkan Cure [Turquie] ; Medine Cumhur Cure [Turquie]Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may be harmful in patients with diabetes during COVID-19 pandemic
000761 (2020) Haibo Zhang [République populaire de Chine, Canada] ; Josef M. Penninger [Autriche] ; Yimin Li [République populaire de Chine] ; Nanshan Zhong [République populaire de Chine] ; Arthur S. Slutsky [Canada, République populaire de Chine]Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target
000762 (2020) Mahmoud Gheblawi ; Kaiming Wang ; Anissa Viveiros ; Quynh Nguyen ; Jiu-Chang Zhong ; Anthony J. Turner [Royaume-Uni] ; Mohan K. Raizada ; Maria B. Grant ; Gavin Y. OuditAngiotensin-Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System
000763 (2020) Tonino Bombardini ; Eugenio PicanoAngiotensin converting enzyme 2 as the molecular bridge between epidemiologic and clinical features of COVID-19

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/StressCovidV1/Data/2020/Analysis

HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/AbsEn.i -k "angiotensin" 

HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/AbsEn.i  \
                -Sk "angiotensin" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/2020/Analysis/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    StressCovidV1
   |flux=    2020
   |étape=   Analysis
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    angiotensin
}}
Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Wed May 6 16:44:09 2020. Site generation: Sun Mar 28 08:26:57 2021